Amgen CDR's market value is the price at which a share of Amgen CDR trades on a public exchange. It measures the collective expectations of Amgen CDR investors about its performance. Amgen CDR is selling at 27.85 as of the 5th of February 2026; that is 1.09% up since the beginning of the trading day. The stock's open price was 27.55. With this module, you can estimate the performance of a buy and hold strategy of Amgen CDR and determine expected loss or profit from investing in Amgen CDR over a given investment horizon. Check out Amgen CDR Correlation, Amgen CDR Volatility and Amgen CDR Performance module to complement your research on Amgen CDR.
Understanding that Amgen CDR's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Amgen CDR represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Amgen CDR's market price signifies the transaction level at which participants voluntarily complete trades.
Amgen CDR 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Amgen CDR's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Amgen CDR.
0.00
11/07/2025
No Change 0.00
0.0
In 3 months and 1 day
02/05/2026
0.00
If you would invest 0.00 in Amgen CDR on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding Amgen CDR or generate 0.0% return on investment in Amgen CDR over 90 days. Amgen CDR is related to or competes with Eli Lilly, Johnson Johnson, IShares Canadian, European Residential, RBC Discount, and IShares SPTSX. Amgen CDR is entity of Canada. It is traded as Stock on TO exchange. More
Amgen CDR Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Amgen CDR's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Amgen CDR upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Amgen CDR's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Amgen CDR's standard deviation. In reality, there are many statistical measures that can use Amgen CDR historical prices to predict the future Amgen CDR's volatility.
As of now, Amgen Stock is very steady. Amgen CDR secures Sharpe Ratio (or Efficiency) of 0.0709, which signifies that the company had a 0.0709 % return per unit of standard deviation over the last 3 months. We have found twenty-seven technical indicators for Amgen CDR, which you can use to evaluate the volatility of the firm. Please confirm Amgen CDR's risk adjusted performance of 0.0587, and Mean Deviation of 1.43 to double-check if the risk estimate we provide is consistent with the expected return of 0.15%. Amgen CDR has a performance score of 5 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.38, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Amgen CDR are expected to decrease at a much lower rate. During the bear market, Amgen CDR is likely to outperform the market. Amgen CDR right now shows a risk of 2.1%. Please confirm Amgen CDR coefficient of variation, jensen alpha, and the relationship between the downside deviation and information ratio , to decide if Amgen CDR will be following its price patterns.
Auto-correlation
-0.32
Poor reverse predictability
Amgen CDR has poor reverse predictability. Overlapping area represents the amount of predictability between Amgen CDR time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Amgen CDR price movement. The serial correlation of -0.32 indicates that nearly 32.0% of current Amgen CDR price fluctuation can be explain by its past prices.
Correlation Coefficient
-0.32
Spearman Rank Test
-0.06
Residual Average
0.0
Price Variance
0.43
Pair Trading with Amgen CDR
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amgen CDR position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen CDR will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Amgen CDR could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amgen CDR when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amgen CDR - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amgen CDR to buy it.
The correlation of Amgen CDR is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amgen CDR moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amgen CDR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amgen CDR can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Amgen CDR financial ratios help investors to determine whether Amgen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amgen with respect to the benefits of owning Amgen CDR security.